First National Bank of Omaha purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 4,464 shares of the company's stock, valued at approximately $1,054,000.
A number of other large investors also recently modified their holdings of the company. BlackRock Inc. purchased a new stake in shares of Cardinal Health during the 2nd quarter worth $6,293,115,000. Norges Bank purchased a new position in Cardinal Health in the fourth quarter valued at $790,344,000. Wellington Management Group LLP raised its stake in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock valued at $911,010,000 after buying an additional 3,511,579 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Cardinal Health in the second quarter valued at $308,640,000. Finally, Deutsche Bank AG purchased a new stake in Cardinal Health during the 2nd quarter worth about $238,933,000. 87.17% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research firms have recently commented on CAH. William Blair began coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an "outperform" rating on the stock. Royal Bank Of Canada started coverage on Cardinal Health in a research note on Wednesday. They set an "outperform" rating and a $276.00 target price for the company. Leerink Partners set a $292.00 price target on Cardinal Health in a report on Tuesday, August 11th. Robert W. Baird increased their price target on shares of Cardinal Health from $251.00 to $274.00 and gave the company an "outperform" rating in a research note on Wednesday, August 12th. Finally, Mizuho raised their price objective on shares of Cardinal Health from $240.00 to $250.00 and gave the stock an "outperform" rating in a report on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has an average rating of "Moderate Buy" and an average target price of $266.56.
Read Our Latest Analysis on CAH
Cardinal Health Stock Down 0.1%
Shares of NYSE CAH opened at $234.73 on Thursday. The business has a 50-day moving average price of $231.76 and a 200 day moving average price of $217.68. The stock has a market cap of $54.59 billion, a PE ratio of 32.47, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a 52-week low of $145.87 and a 52-week high of $258.30.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The company's revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.
Cardinal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 28.49%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.